Abdo Haddad
Impact in
- Internal Medicine top 10%
- Venous Thromboembolism Diagnosis and Management
- Hematology top 10%
- Acute Myeloid Leukemia Research
Papers in ⓘ
-
- Lung Cancer Treatments and Mutations 4
- Oncology 13
- Inflammatory Biomarkers in Disease Prognosis 3
- Cancer Immunotherapy and Biomarkers 3
- Co-authors
- Hamed Daw (28 shared papers)Timothy Spiro (9 shared papers)Mellar P. Davis (2 shared papers)Ruth Lagman (2 shared papers)Jaroslaw P. Maciejewski (4 shared papers)Xuefei Jia (2 shared papers)Karl S. Theil (2 shared papers)Tariq Kewan (9 shared papers)
- Journals
- Journal of Clinical Oncology (7 papers)Anti-Cancer Drugs (2 papers)American Journal of Therapeutics (2 papers)Supportive Care in Cancer (2 papers)Journal of Oncology Practice (2 papers)
- Partner nations
- United StatesCanadaJapan
In The Last Decade
Abdo Haddad
35 papers receiving 421 citations
Peers
Comparison fields: 5 of 69
- Internal Medicine 42
- Hematology 83
- Oncology 143
- Genetics 55
- Cardiology and Cardiovascular Medicine 106
Countries citing papers authored by Abdo Haddad
This map shows the geographic impact of Abdo Haddad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Abdo Haddad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Abdo Haddad more than expected).
Fields of papers citing papers by Abdo Haddad
This network shows the impact of papers produced by Abdo Haddad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Abdo Haddad. The network helps show where Abdo Haddad may publish in the future.
Co-authors
The 25 scholars most cited alongside Abdo Haddad, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 41 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 83 | |
| 2 | 2006 | 47 | |
| 3 | 2007 | 39 | |
| 4 | 2007 | 33 | |
| 5 | 2009 | 28 | |
| 6 | 2012 | 23 | |
| 7 | 2021 | 21 | |
| 8 | 2021 | 21 | |
| 9 | 2018 | 18 | |
| 10 | 2022 | 14 | |
| 11 | 2013 | 12 | |
| 12 | 2022 | 12 | |
| 13 | 2019 | 12 | |
| 14 | 2018 | 11 | |
| 15 | 2020 | 7 | |
| 16 | 2016 | 6 | |
| 17 | 2021 | 5 | |
| 18 | 2011 | 5 | |
| 19 | 2018 | 5 | |
| 20 | 2021 | 4 |
About Abdo Haddad
Abdo Haddad is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Surgery, Genetics and Pathology and Forensic Medicine, having authored 41 papers that have together received 434 indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (5 papers), Venous Thromboembolism Diagnosis and Management (5 papers), Lung Cancer Treatments and Mutations (4 papers), Acute Myeloid Leukemia Research (3 papers), Inflammatory Biomarkers in Disease Prognosis (3 papers), Chronic Lymphocytic Leukemia Research (3 papers), Cancer Immunotherapy and Biomarkers (3 papers) and Cancer Genomics and Diagnostics (3 papers). The work is most often cited by research in Internal Medicine (42 citations), Hematology (83 citations), Oncology (143 citations), Genetics (55 citations) and Cardiology and Cardiovascular Medicine (106 citations). Abdo Haddad has collaborated with scholars based in United States, Canada and Japan. Frequent co-authors include Hamed Daw, Timothy Spiro, Mellar P. Davis, Ruth Lagman, Jaroslaw P. Maciejewski, Xuefei Jia, Karl S. Theil, Tariq Kewan, Manmeet S. Ahluwalia and G. Thomas Budd. Their work appears in journals such as Journal of Clinical Oncology, Anti-Cancer Drugs, American Journal of Therapeutics, Supportive Care in Cancer and Journal of Oncology Practice.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.